Drug Use Investigation Of Gabapentin

Trial Profile

Drug Use Investigation Of Gabapentin

Phase of Trial: Phase IV

Latest Information Update: 18 May 2015

At a glance

  • Drugs Gabapentin (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 10 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Apr 2013 Planned end date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 13 May 2011 Planned End Date changed from 1 Dec 2009 to 1 Mar 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top